The Washington Court of Appeals has reversed personal sanctions imposed on attorneys representing Pharmacia LLC in a case involving claims of exposure to polychlorinated biphenyls (PCBs). The sanctions were originally issued by a trial court for the late disclosure of expert witnesses, but the appellate court found that the trial court exceeded its authority under the applicable rules. This decision affects the attorneys involved and clarifies the limits of sanctions that can be imposed for discovery violations.

The case, Gunnar L.G. Rose et al. v. Pharmacia LLC, was filed in 2018 when several plaintiffs, including Gunnar Rose and Donya Grant, alleged damages due to PCB exposure. The lawsuits were consolidated in June 2024, just as the deadline for disclosing expert witnesses had passed. Pharmacia had initially disclosed expert witnesses for both cases but later attempted to introduce additional expert opinions after the deadline.

During a deposition in August 2024, one of Pharmacia's experts revealed plans to provide opinions related to the Grant case. Consequently, Pharmacia disclosed additional expert reports in September 2024, which led the plaintiffs to file a motion to strike these reports as untimely. The trial court held a hearing on the matter and expressed concern over the disruption caused by Pharmacia's late disclosures.

After Pharmacia withdrew the late disclosures, the plaintiffs requested sanctions for the time spent preparing their motions. The trial court acknowledged the plaintiffs' valid concerns and ordered Pharmacia to pay attorney fees related to the motions. Additionally, the court imposed personal sanctions of $2,500 against each of Pharmacia's eight attorneys, citing a pattern of disruptive behavior in the case.

Pharmacia's attorneys appealed the sanctions, arguing that the trial court had erred in imposing personal punitive sanctions under Washington Civil Rule 37(b)(2). The appellate court agreed, stating that the rule does not authorize personal punitive sanctions for violations of discovery orders. The court emphasized that the trial court's decision to impose personal sanctions was based on an erroneous interpretation of the law.

The court ruled, "Because CR 37(b)(2) does not authorize personal punitive sanctions for violation of a discovery order, we reverse and remand for the trial court to vacate those sanctions."

The appellate court explained that the purpose of sanctions is to deter, punish, compensate, and educate, and that the trial court had broad discretion to impose sanctions for discovery violations. However, the court concluded that the specific types of sanctions outlined in CR 37(b)(2) did not include personal punitive measures against attorneys.

The ruling clarifies that while attorney fees can be imposed as a sanction, personal punitive sanctions are not permissible under the current rules governing discovery violations. This decision may impact future cases where attorneys face sanctions for similar conduct, as it sets a precedent regarding the limits of judicial authority in imposing personal penalties.

Going forward, this ruling may influence how courts handle sanctions in discovery disputes. Attorneys and parties involved in litigation should be aware of the specific rules governing sanctions to avoid potential penalties. The appellate court's decision reinforces the importance of adhering to procedural rules and the need for clear communication regarding expert witness disclosures.

Pharmacia's attorneys may still face other forms of sanctions if warranted under different rules, such as CR 11, which addresses baseless filings and abusive litigation conduct. However, the appellate court's ruling specifically addresses the limitations of CR 37(b)(2) in imposing personal punitive sanctions.

As for next steps, the plaintiffs may choose to seek further clarification from the trial court regarding any remaining issues in the case. The appellate court's decision does not preclude the possibility of other sanctions being imposed under different legal standards. Details were not available in the court filing regarding any related cases or potential appeals following this ruling.